Compare StocksBAC vs WST

Bank of America Corporation (BAC) vs West Pharmaceutical Services, Inc. (WST): Which Is the Better Buy in 2026?

As of 2026-06-19, BAC is undervalued at $56, with a DCF intrinsic value of $133 and a margin of safety of 58%. WST is overvalued at $328, with an intrinsic value of $184 and a margin of safety of -78%. Of the two, BAC has the wider margin of safety.

BAC
Bank of America Corporation
$56.20
VS
WST
West Pharmaceutical Services, Inc.
$327.95

Rewards

BAC
  • Bank of America Corporation scores 100/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
WST
  • West Pharmaceutical Services, Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Altman Z-Score of 13.89 indicates very low bankruptcy risk — the company is firmly in the safe zone.
  • Net debt/EBITDA of -0.2x means the company holds more cash than debt — a net cash position.

Risks

BAC
  • Gross margin of 0.0% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • Altman Z-Score of 0.22 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
WST
  • FCF yield of 2.0% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • PEG ratio of 3.17 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.

Key Valuation Metrics

Learn more →
BAC
WST
Valuation
N/A
Free Cash Flow
$468.90M
N/A
FCF Yield
2.02%
13.95
Trailing P/E
43.84
11.13
Forward P/E
34.32
Quality & Moat
3.89%
ROIC
16.67%
10.64%
ROE
19.13%
0.00%
Gross Margin
36.28%
1.02
PEG Ratio
3.17
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
N/A
Net Debt / EBITDA
-0.23
1.97%
Dividend Yield
0.27%
BAC: 4Ties: 1WST: 3
BACWST

Historical Fundamentals

Learn more →
BAC

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

WST

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
BAC
$2.37
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$55.63B
Δ Market Cap
+$131.83B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
WST
$1.70
created per $1 retained over 3 years
Value Creator
Σ Retained
$1.40B
Δ Market Cap
+$2.38B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
BAC
57.9% Margin of Safety
Price is 57.9% below estimated fair value
Current Price: $56.20
Fair Value: $133.45
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
WST
77.9% Overvalued
Price is 77.9% above estimated fair value
Current Price: $327.95
Fair Value: $184.37
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
BAC

Requires positive FCF to compute implied growth rate.

WST

What growth rate is the market pricing in at $328?

+19.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +19.9%

The market implies +19.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +19.9%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
BAC
100/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Reinvestment Efficiency is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
WST
68/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving margin stability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
BAC
-2.31
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
WST
-2.77
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
BAC
Insiders 7.3%Institutions 70.6%Retail & Other 22.0%
No. of Institutional Holders4,373
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
WST
Insiders 0.6%Institutions 104.0%
No. of Institutional Holders1,117
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
BAC
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
WST
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
BAC
0
Sells (3M)
5
Sells (12M)
Total value (12M): $20.17M
MENSAH BERNARD AMPONSAH
Officer
$4.41M
@ $46.94 · 2026-03-12
SCRIVENER THOMAS M
Officer
$2.49M
@ $49.82 · 2026-03-05
BRONSTEIN SHERI B
Officer
$2.99M
@ $49.91 · 2026-03-05
ATHANASIA DEAN C
President
$6.86M
@ $50.21 · 2026-03-03
BORTHWICK ALASTAIR M.
Chief Financial Officer
$3.42M
@ $50.24 · 2026-02-27
MENSAH BERNARD AMPONSAH
Officer
$3.66M
@ $39.80 · 2024-08-27
HANS LINDSAY D
Officer
$402,410
@ $36.91 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
WST
2
Sells (3M)
2
Sells (12M)
Total value (12M): $1.13M
FAVORITE ANNETTE F
Officer
$859,753
@ $305.20 · 2026-04-27
WINTERS CHAD
Officer
$269,399
@ $300.67 · 2026-04-27
WITHERSPOON CHARLES
Officer and Treasurer
$218,211
@ $310.40 · 2024-10-29
WITHERSPOON CHARLES
Officer and Treasurer
$308,700
@ $300.00 · 2024-08-19
GREEN ERIC MARK
Chief Executive Officer
$9.36M
@ $304.71 · 2024-08-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
BAC
FearGreed
😏Greed(74/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
WST
FearGreed
😏Greed(64/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
BAC
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (74)
WST
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (64)
View BAC Full AnalysisView WST Full Analysis

Frequently Asked Questions: BAC vs WST

Is Bank of America Corporation or West Pharmaceutical Services, Inc. more undervalued in 2026?

Based on our discounted cash flow model, BAC trades at a 57.9% margin of safety (intrinsic value $133 vs. price $56), compared to WST's -77.9% margin of safety (intrinsic $184 vs. $328).

Which stock has a wider economic moat, Bank of America Corporation or West Pharmaceutical Services, Inc.?

BAC scores 100/100 (Wide moat), while WST scores 68/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Bank of America Corporation in financial distress?

BAC's Altman Z-Score of 0.2 places it in the Distress zone, signaling elevated bankruptcy risk. WST scores 13.9 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Bank of America Corporation or West Pharmaceutical Services, Inc.?

WST earns 16.7% ROIC versus BAC's 3.9%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Bank of America Corporation's or West Pharmaceutical Services, Inc.'s?

WST's dividend earns a safety score of 94/100 (Very Safe), compared to BAC's 79/100 (Safe). WST has raised its dividend for 3 consecutive years.